Compounds > galactose
Page last updated: 2024-08-17

galactose and Liver Failure

galactose has been researched along with Liver Failure in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balachander, B; Bharadwaj, SK; Bhat, BV; Mondal, N1
Jalanko, H; Kosola, S; Lampela, H; Pakarinen, MP1
Ott, P; Schmidt, LE; Tygstrup, N1
Batømunkh, M; Hagihara, M; Shimura, T; Takebe, K; Tsuji, K1
Becker, H; Ebener, C; Roeher, HD; Zoedler, T1
Banchereau, J; Byrne, G; Crippin, J; Curiel, T; Diamond, LE; Goldstein, RM; Gonwa, TA; Klintmalm, GB; Levy, MF; Logan, J; McCormack, J; Netto, G; Newman, JT; Sutton, S1

Other Studies

6 other study(ies) available for galactose and Liver Failure

ArticleYear
Negative Urine Benedict's Test in a Child with Galactosemia: A Diagnostic Challenge.
    Indian journal of pediatrics, 2015, Volume: 82, Issue:8

    Topics: Carbonates; Citrates; Copper; Cyanates; False Negative Reactions; Female; Galactose; Galactosemias; Humans; Infant, Newborn; Liver Failure

2015
Galactose half-life is a useful tool in assessing prognosis of chronic liver disease in children.
    Transplant international : official journal of the European Society for Organ Transplantation, 2012, Volume: 25, Issue:10

    Topics: Adolescent; Biliary Atresia; Child; Child, Preschool; Cohort Studies; End Stage Liver Disease; Galactose; Humans; Infant; Liver Failure; Liver Transplantation; Predictive Value of Tests; Prognosis; ROC Curve; Sensitivity and Specificity; Treatment Outcome

2012
Galactose elimination capacity as a prognostic marker in patients with severe acetaminophen-induced hepatotoxicity: 10 years' experience.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2004, Volume: 2, Issue:5

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Clinical Enzyme Tests; Female; Galactose; Humans; Liver Failure; Liver Function Tests; Liver Transplantation; Logistic Models; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Prognosis; ROC Curve

2004
Iso and xeno fetal liver transplant therapy for the treatment of acute and chronic liver failure in rats.
    Cell transplantation, 1994, Volume: 3 Suppl 1

    Topics: Animals; Carbon Tetrachloride Poisoning; Chronic Disease; Fetal Tissue Transplantation; Galactose; Liver Failure; Liver Failure, Acute; Liver Transplantation; Necrosis; Rats; Rats, Wistar; Swine; Transplantation, Heterologous; Transplantation, Isogeneic

1994
Evaluation of liver function tests to predict operative risk in liver surgery.
    HPB surgery : a world journal of hepatic, pancreatic and biliary surgery, 1995, Volume: 9, Issue:1

    Topics: Galactose; Humans; Indocyanine Green; Lidocaine; Liver Diseases; Liver Failure; Liver Function Tests; Postoperative Complications; Predictive Value of Tests; Risk Factors

1995
Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus.
    Transplantation, 2000, Jan-27, Volume: 69, Issue:2

    Topics: Adolescent; Animals; Animals, Genetically Modified; Antibodies; Extracorporeal Circulation; Female; Fluorescent Antibody Technique, Direct; Galactose; Humans; Immunohistochemistry; Liver Failure; Liver Transplantation; Male; Perfusion; Retroviridae Infections; Swine; Transplantation, Homologous

2000